116 related articles for article (PubMed ID: 29415871)
1. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of eslicarbazepine: current evidence.
Zaccara G; Giovannelli F; Cincotta M; Carelli A; Verrotti A
Drug Des Devel Ther; 2015; 9():781-9. PubMed ID: 25709402
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy.
Kim JS; Kim WS; Sung WY; Woo H
Epilepsy Behav; 2024 May; 154():109740. PubMed ID: 38547767
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy.
Hirsch M; Immisch I; Knake S; Schulze-Bonhage A
CNS Drugs; 2023 Nov; 37(11):973-980. PubMed ID: 37921919
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of levetiracetam and carbamazepine monotherapy in the management of pediatric focal epilepsy: a randomized clinical trial.
Montazerlotfelahi H; Haj Mohamad Ebrahim Ketabforoush A; Tavakol M; Ashrafi M; Dehghani M; Mostafavi K; Mardi S; Tajfirooz S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5233-5240. PubMed ID: 38265679
[TBL] [Abstract][Full Text] [Related]
6. Eslicarbazepine acetate (BIA 2-093).
Almeida L; Soares-da-Silva P
Neurotherapeutics; 2007 Jan; 4(1):88-96. PubMed ID: 17199020
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam prescription profile in children younger than 4 years treated at a tertiary care hospital in Chile.
Kyonen M; Acuña L; Ramos B; Gutiérrez J; Barría RM
Arch Argent Pediatr; 2024 Aug; 122(4):e202310233. PubMed ID: 38457309
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Levetiracetam for Childhood Epilepsies.
Catibusic FH; Uzicanin S; Salihbegovic EV; Huseinbegovic Z
Med Arch; 2024; 78(2):122-126. PubMed ID: 38566869
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Levetiracetam and Carbamazepine as Monotherapy in Partial Seizures.
Suresh SH; Chakraborty A; Virupakshaiah A; Kumar N
Epilepsy Res Treat; 2015; 2015():415082. PubMed ID: 26798511
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric assessment prior to and after switch from levetiracetam to brivaracetam.
Kassoum A; Intravooth T; Wendling AS; Staack AM; Steinhoff BJ
Seizure; 2024 Apr; 117():193-197. PubMed ID: 38460458
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam induces severe psychiatric symptoms in people with epilepsy.
Tao K; Chen H; Chen Y; Gu Y; Wang X
Seizure; 2024 Mar; 116():147-150. PubMed ID: 36535885
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring in pregnancy: Levetiracetam.
Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and neurotransmitter changes on antiepileptic drugs treatment in the zebrafish pentylenetetrazol-induced seizure model.
Okanari K; Teranishi H; Umeda R; Shikano K; Inoue M; Hanada T; Ihara K; Hanada R
Behav Brain Res; 2024 Apr; 464():114920. PubMed ID: 38403178
[TBL] [Abstract][Full Text] [Related]
14. Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review.
Liu R; Xiao L; Liu X; Xiao C
Medicine (Baltimore); 2024 Apr; 103(17):e37977. PubMed ID: 38669358
[TBL] [Abstract][Full Text] [Related]
15. Antiepileptic drugs and psychopathology of epilepsy: an update.
Mula M; Monaco F
Epileptic Disord; 2009 Mar; 11(1):1-9. PubMed ID: 19258231
[TBL] [Abstract][Full Text] [Related]
16. Effect of levetiracetam drug on antioxidant and liver enzymes in epileptic patients: case-control study.
Mahdavi A; Naeini AA; Najafi M; Maracy M; Ghazvini MA
Afr Health Sci; 2020 Jun; 20(2):984-990. PubMed ID: 33163067
[TBL] [Abstract][Full Text] [Related]
17. Comparative Outcomes of Levetiracetam and Phenobarbital Usage in the Treatment of Neonatal Seizures: A Retrospective Analysis.
Toptan HH; Karadag NN; Topcuoglu S; Ozalkaya E; Dincer E; Cakir H; Gunes AO; Karatekin G
Healthcare (Basel); 2024 Apr; 12(7):. PubMed ID: 38610222
[TBL] [Abstract][Full Text] [Related]
18. Assessing the Effectiveness of Eslicarbazepine Acetate in Reducing Audiogenic Reflex Seizures in the GASH/Sal Model of Epilepsy.
Gonçalves-Sánchez J; Ramírez-Santos T; López DE; Gonçalves-Estella JM; Sancho C
Biomedicines; 2024 May; 12(5):. PubMed ID: 38791083
[TBL] [Abstract][Full Text] [Related]
19. A highlight on carbamazepine-induced adverse drug reactions in Saudi Arabia: a retrospective medical records-based study.
Sukkarieh HH; Khokhar AA; Bustami RT; Karbani GA; Alturki FA; Alvi SN
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3177-3182. PubMed ID: 37199768
[TBL] [Abstract][Full Text] [Related]
20. Structural connectivity as a predictive factor for responsiveness to levetiracetam treatment in epilepsy.
Lee DA; Lee HJ; Park KM
Neuroradiology; 2024 Jan; 66(1):93-100. PubMed ID: 38015213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
